| Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells D Samanta, Y Park, X Ni, H Li, CA Zahnow, E Gabrielson, F Pan, ... Proceedings of the National Academy of Sciences 115 (6), E1239-E1248, 2018 | 292 | 2018 |
| PHGDH expression is required for mitochondrial redox homeostasis, breast cancer stem cell maintenance, and lung metastasis D Samanta, Y Park, SA Andrabi, LM Shelton, DM Gilkes, GL Semenza Cancer research 76 (15), 4430-4442, 2016 | 231 | 2016 |
| Chemotherapy-induced Ca2+ release stimulates breast cancer stem cell enrichment H Lu, I Chen, LA Shimoda, Y Park, C Zhang, L Tran, H Zhang, ... Cell reports 18 (8), 1946-1957, 2017 | 157 | 2017 |
| Reciprocal regulation of DUSP9 and DUSP16 expression by HIF1 controls ERK and p38 MAP kinase activity and mediates chemotherapy-induced breast cancer stem cell enrichment H Lu, L Tran, Y Park, I Chen, J Lan, Y Xie, GL Semenza Cancer research 78 (15), 4191-4202, 2018 | 82 | 2018 |
| Fractalkine induces angiogenic potential in CX3CR1-expressing monocytes Y Park, J Lee, JY Kwak, K Noh, E Yim, HK Kim, YJ Kim, HE Broxmeyer, ... Journal of leukocyte biology 103 (1), 53-66, 2018 | 26 | 2018 |
| STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer A Taber, Y Park, A Lelo, F Prip, J Xiao, DL Berry, K Chaldekas, JB Jensen, ... Urologic Oncology: Seminars and Original Investigations 39 (7), 438. e1-438. e9, 2021 | 13 | 2021 |
| Context-dependent neocentromere activity in synthetic yeast chromosome VIII S Lauer, J Luo, L Lazar-Stefanita, W Zhang, LH McCulloch, V Fanfani, ... Cell Genomics 3 (11), 2023 | 9 | 2023 |
| Identification of STAG2-mutant bladder cancers by immunohistochemistry Y Park, A Lelo, B Harris, DL Berry, K Chaldekas, JS Kim, T Waldman Urothelial Carcinoma: Methods and Protocols, 145-151, 2023 | 3 | 2023 |
| The prognostic significance of CD11b+ CX3CR1+ monocytes in patients with newly diagnosed diffuse large B-cell lymphoma HY Yhim, JA Kim, SH Ko, Y Park, E Yim, HS Kim, JY Kwak Oncotarget 8 (54), 92289, 2017 | 3 | 2017 |
| Fractalkine/CX3CR1 Signaling Promotes Angiogenic Potentials in CX3CR1 Expressing Monocytes JA Kim, JY Kwak, Y Eunjung, J Lee, Y Park, HE Broxmeyer Blood 128 (22), 2507, 2016 | 2 | 2016 |
| Ex Vivo Culture with Albumin Greatly Increases the Immunosuppressive Subset of T Lymphocytes JA Kim, J Kim, S Kim, M Yang, Y Park, JY Kwak Blood 140 (Supplement 1), 4538-4539, 2022 | | 2022 |
| The Role of STAG2 in Bladder Cancer: Clinical Implications as a Biomarker and Potential Mechanisms of Tumorigenesis Y Park Georgetown University, 2022 | | 2022 |
| Ex Vivo IL-2 Treatment Increases the Immunosuppressive Subset of T Lymphocytes to Suppress Allo-Immune Response JA Kim, KIM Jinhang, M Yang, Y Park, JY Kwak Blood 138, 2066, 2021 | | 2021 |
| Pigment Epithelium-Derived Factor Promotes the Angiogenic Activity of VEGF JA Kim, M Yang, YH Park, Y Park, JY Kwak Blood 132, 3687, 2018 | | 2018 |
| Fractalkine Treated of CD11b+ CX3CR1+ Monocytes Promotes Angiogenesis through Pigment Epithelium-Derived Factor JA Kim, JY Kwak, J Lee, Y Park, HE Broxmeyer Blood 130, 1026, 2017 | | 2017 |
| THE PROGNOSTIC SIGNIFICANCE OF CD11B+ CX3CR1+ MONOCYTES IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA JY Kwak, JA Kim, HY Yhim, SH Ko, Y Park HAEMATOLOGICA 102, 392-393, 2017 | | 2017 |
| The Role of CD11b+ CX3CR1+ Cells in Neovascularization JA Kim, JY Kwak, K Noh, J Lee, Y Park, HE Broxmeyer Blood 124 (21), 4180, 2014 | | 2014 |
| CLINICAL IMPACT OF INCLUSION AND TIMING OF RADIOTHERAPY IN THE TREATMENT OF LIMITED-STAGE NK/T-CELL LYMPHOMA BH Lee, JA Kim, HY Yhim, JY Kwak, YR Do, Y Park, MK Song, JS Chung, ... HAEMATOLOGICA 99, 153-153, 2014 | | 2014 |
| The Role Of CD11b+ CX3CR1+ Cells In Neovascularization JA Kim, JY Kwak, K Noh, HK Kim, B Lee, Y Park, YJ Kim, HE Broxmeyer Blood 122 (21), 2301, 2013 | | 2013 |
